医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″

2017年10月18日 PM02:30
このエントリーをはてなブックマークに追加


 

TOKYO

Shinkowa Pharmaceutical Co., Ltd. (Chuo-ward, Tokyo; CEO, Megumi Tanaka) sells the first ever original supplements and cosmetics containing β-nicotinamide mononucleotide (NMN) under the “MIRAILAB” supplement brand and the “MIRAIDA” cosmetic brand, respectively.
The company has begun world-wide distribution of the special supplement products “NMN PURE 3000″ and “NMN PURE 1500″, which contain high doses of NMN.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171017005722/en/

NMN PURE 3000 (Photo: Business Wire)

NMN PURE 3000 (Photo: Business Wire)

[About NMN]
NMN is an abbreviation of β-nicotinamide mononucleotide, which is contained in vitamin B3s and exists naturally in the tissues and cells of organisms.

NMN is transformed in the body to a substance called nicotinamide adenine dinucleotide (NAD), which is necessary for us to maintain body functions, and is known to enhance the activities of 7 types of sirtuin genes (SIRT 1-7) as well as the function of mitochondria within the cells.

Mitochondria produce adenosine triphosphate (ATP), known as the “molecular unit of currency”, and play a role in providing energy to the cells. SIRT 1 is important in promoting the cooperation of the nucleus and mitochondria within the cells.

As mitochondria function decreases with aging, the production of NMN in the body decreases, and the amount of NAD decreases accordingly.
When taken orally, about 90% of the NAD is destroyed in the digestive organs, therefore NMN, which is not destroyed in the digestive organs, needs to be supplemented from outside the body. NMN intake enhances the function of mitochondria, and rejuvenation and anti-aging are anticipated with the activation of sirtuin genes.

Sirtuin genes play an important role in controlling aging and longevity. Proteins produced from sirtuin genes prevent aging and are involved in energy metabolism.
For example, the functions of the muscles, etc. are known to be kept young when the function of SIRT1 is enhanced by NMN in the hypothalamus of the brain. The hypothalamus is considered to play the role of the “control center” that regulates aging. Commands from the hypothalamus are conveyed to the skeletal muscles, and a hormone-like substance that adjusts the body function is excreted from the skeletal muscles to keep the muscles young. Therefore, NMN is expected to be effective not only for decreasing body functions associated with aging but also for locomotive syndrome, which makes walking difficult due to the weakening of the legs, and sarcopenia, which is associated with a decrease in muscle mass.

NMN is also expected to be effective for various functions that are weakened with aging and diseases, including the improvements in the blood glucose level in patients with type 2 diabetes and pre-diabetes in whom the blood glucose levels become higher than normal, prevention of Alzheimer’s disease, neurodegenerative disease, heart failure, and metabolic syndrome, as well as increased bone mineral density and the improved immunity. These conditions have already been confirmed to be resolved and improved after treatment with NMN in studies with mice.

[Product Overview]
(1) NMN PURE 3000
Price: US$1098
Size: 60 capsules (50 mg of NMN/capsule, 3,000 mg of NMN/bottle)
Serving: 1-2 capsules/day
Ingredients: starch, nicotinamide mononucleotide
Supplement facts: (serving size: 2 capsules):   Calories 1.89 kcal/Protein 0.03 g/Fat 0.00 g/Carbohydrate 0.43 g/Sodium 0.36 mg/Salt 0.001 g
 
(2) NMN PURE 1500
Price: US$607
Size: 60 capsules (25 mg of NMN/capsule, 1,500 mg of NMN/bottle)
Serving: 2-4 capsules/day
Ingredients: Starch, nicotinamide mononucleotide
Supplement facts: (serving size: 4 capsules): Calories 4.76 kcal /Protein 0.04 g/Fat 0.00 g/Carbohydrate 1.13 g/Sodium 0.76 mg/Salt 0.001 g
 

[Purchase]
Available online at the following address:

US Amazon
https://www.amazon.com/sp?_encoding=UTF8&asin=&isAmazonFulfilled=&isCBA=&marketplaceID=ATVPDKIKX0DER&orderID=&seller=A2RIWHOCVBWP9H&tab=&vasStoreID=

[Precautions]
The NMN contained in the NMN-containing supplements and cosmetics distributed by Shinkowa Pharmaceutical Co., Ltd. is 98% or more in purity, and its safety has been confirmed by acute toxicity test, primary skin irritation test, eye irritation test and reverse mutation test.

This product information is intended for customers to use as a reference when selecting products and is not a substitute for the opinions of physicians, pharmacists and other qualified specialists. It cannot be used for self-diagnosis to cure diseases. Please consult with your doctor before purchase if you have allergies or are pregnant.

After you receive the product, please avoid subjecting it to direct sunlight, high temperature and humidity and store it in a dark, cool place such as in a refrigerator even before opening.

[Company Profile]
Company name: Shinkowa Pharmaceutical Co.,Ltd.
Representative: Megumi Tanaka, CEO
Address: 2-30-11 Shinkawa, Chuo-Ward, Tokyo 104-0033 Japan
Business description: Health food/cosmetics distribution, trade business
URL: http://shinkowapharma.com/

View source version on businesswire.com: http://www.businesswire.com/news/home/20171017005722/en/

CONTACT

Shinkowa Pharmaceutical Co.,Ltd.
Daizo Shimamura, +81 3-5403-6393
E-mail:
info@shinkowapharma.com
Please
contact us by E-mail in either English or Japanese since we may not be
able to respond to inquiries in other languages.

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre for Proteomics and Mass Spectrometry Across Asia Pacific
  • Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Australia, New Zealand and South East Asia
  • Preceptis Medical宣布面向中国的B轮融资和全球增长战略
  • オクタファルマ、開発途上国の血友病患者を治療するために当社のNuwiq製剤3050万国際単位を寄付
  • Octapharma捐赠3050万国际单位该公司药品 Nuwiq以治疗发展中国家的血友病患者